Home > Healthcare > Medical Devices > Therapeutic Devices > Insulin Delivery Devices Market

Insulin Delivery Devices Market Trends

Report ID: GMI1649
Published Date: Sep 2023
Report Format: PDF

Download Free Sample

Insulin Delivery Devices Market Trends

Rising advancements in insulin delivery devices intended to improve the comfort, safety, and overall well-being of individuals suffering from diabetes will spur business evolution. Introduction of digital diabetes management technologies and their integration into insulin delivery devices has offered highly reliable and convenient solutions to patients. Continuous efforts by the organizations for the development of innovative products providing ease in insulin delivery and blood glucose level monitoring with an active lifestyle will accelerate the product adoption.

Further, the launch of bluetooth-enabled wearable devices with continuous glucose monitoring systems has allowed real-time monitoring and insulin delivery at the required stage. For instance, Insulet Corporation received the U.S. FDA approval for the Omnipod DASH Insulin Management System with a bluetooth connectivity, and personal diabetes manager. Bluetooth feature of the system enables connectivity to Omnipod display and Omnipod view apps providing quick access to insulin therapy information to patients as well as professionals on their smartphones.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Insulin delivery devices market size was USD 16.9 billion in 2022 and will reach over USD 46.3 billion by 2032 due to the increasing prevalence of diabetes worldwide.

The insulin pumps device type segment will witness 12.3% CAGR from 2023-2032 on account of benefits, such as, affordable price, user-friendly design, and technological advancements.

U.S. industry registered over USD 19 billion in revenue in 2022 and is expected to witness significant CAGR from 2023-2032 owing to the growing burden of diabetic conditions in the region.

Novo Nordisk A/S, Ypsomed Holdings AG, Medtronic plc, Tandem Diabetes Care, Sanofi, Biocon, Eli Lilly & Company, Insulet Corporation, Roche, and B Braun Melsungen AG are some of the major insulin delivery device companies worldwide.